CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TRVITrevi Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $14.32 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$2.04B
RECENT INSIDER TRADES
  • 2026-09-17 · Heffernan Michael Thomas (Director) · OTHER
  • 2026-09-17 · Heffernan Michael Thomas (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders228
Shares held158,949,670
Value$2.85B
Percent of shares outstanding111.56%
As of quarter end2026-06-30
RECENT NEWS
  • BMO reiterates Trevi Therapeutics stock rating after rival study fails
  • Trevi Therapeutics presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS